Table 1.
Main baseline epidemiological characteristics of the patients.
| Variable | |
|---|---|
| Sex (M/F), n (%) | 15 (51.7)/14 (48.3) |
| Age at study onset (yrs.), m (SD) | 38.6 (10.7) |
| Psoriasis duration (yrs.), median (IQR) | 18 (9–27) |
| Current smokers, n (%) | 10 (34.5) |
| Weight (Kg), m (SD) | 78.8 (15.5) |
| BMI (Kg/m2), m (SD) | 27.5 (3.7) |
| Waist perimeter (cm), m (SD) | 96.1 (10.8) |
| Systolic BP (mm Hg), m (SD) | 120.3 (12.4) |
| Diastolic BP (mm Hg), m (SD) | 75.0 (6.8) |
| BSA (%), m (SD) | 37.9 (16.3) |
| PASI, m (SD) | 18.9 (7.8) |
| ESR (mm/1st h), median (IQR) | 10 (4–21) |
| hs-CRP (mg/dL), median (IQR) | 0.29 (0.07–0.58) |
| Fat percentage, (%) | 32.7 (8.8) |
| TBS (unitless), m (SD) | 1.448 (0.102) |
BMI: body mass index. BP: blood pressure. BSA: percent of body surface area affected. PASI: Psoriasis Area and Severity Index. ESR: erythrocyte sedimentation rate. hs-CRP: high-sensitive C-reactive protein. TBS: trabecular bone score.